Rani Therapeutics Holdings (RANI) Shares Outstanding (Diluted) (2021 - 2026)

Rani Therapeutics Holdings (RANI) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 52.24 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.51 Bn
4 NuCana 279.75 Bn 279.75 Bn - 10.00
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 256.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 107.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 680.00
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 64.41 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 198.10 Mn
10 Rani Therapeutics Holdings 160.20 Mn 167.33 Mn - 180.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 180.00 Mn
Dec 31, 2025 66,138.00
Sep 30, 2025 46.44 Mn
Jun 30, 2025 36.54 Mn
Mar 31, 2025 33.44 Mn
Dec 31, 2024 28,476.00
Sep 30, 2024 28.84 Mn
Jun 30, 2024 26.32 Mn
Mar 31, 2024 26.03 Mn
Dec 31, 2023 25,505.00
Sep 30, 2023 25.55 Mn
Jun 30, 2023 25.35 Mn
Mar 31, 2023 25.24 Mn
Dec 31, 2022 23,817.00
Sep 30, 2022 24.47 Mn
Jun 30, 2022 24.37 Mn
Mar 31, 2022 21.41 Mn
Dec 31, 2021 19,534.00
Sep 30, 2021 19.44 Mn